OTCM
SHPPF
Market cap1.81bUSD
Feb 06, Last price
150.26USD
Name
Shop Apotheke Europe NV
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
10.73%
Rev. 5Y
34.44%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.37b
+96.83%
Net income
-45m
L-41.45%
CFO
22m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Redcare Pharmacy N.V. operates an extensive network of online pharmacies, serving customers in a number of European nations including Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a broad array of health and wellness products, from prescribed and over-the-counter medicines to a variety of beauty and personal care items typically found in pharmacies, as well as dietary supplements. Founded in 2001, the enterprise was formerly recognized as Shop Apotheke Europe N.V. before officially adopting the name Redcare Pharmacy N.V. in June 2023. Its headquarters are situated in Sevenum, the Netherlands.
Key people
Chief Executive Officer, Member of the Management Board · since 2023
Frank Koehler
Vice Chairman of the Supervisory Board · since 2021
Theresa Holler
Chief Operating Officer, Member of the Management Board
Lode Fastree
Chief Information Officer, Member of the Management Board · since 2024
Dirk Bruese
CCO, Member of the Management Board · since 2024
Jasper Eenhorst
Chief Financial Officer, Member of the Management Board · since 2020
Bjoern Soeder
Chairman of the Supervisory Board · since 2021
Jerome Cochet
Independent Member of the Supervisory Board · since 2022
Member of the Supervisory Board · since 2022
Henriette Peucker
Member of the Supervisory Board · since 2021
IPO date
Oct 13, 2016
Employees
1,638
Domiciled in
NL
Incorporated in
NL
Headquarters & legal address
Erik de Rodeweg 11
Sevenum, LI 5975 WD
NL
Sevenum, LI 5975 WD
NL
Previous name
Shop Apotheke Europe N.V.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT |